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When eCAM was first born in 2004 we recognized our
role in the world of integrative medicine, which is to
become the model publication devoted to evidence-based
approaches, thus the name ‘evidence based’. Recognition
was given to the fact that eCAM is a part of a larger
compendium of information, technologies and ideas that
increasingly overlap and intertwine in a tangled web of
biological processes. There are sometimes interfacing
and even colliding influences that include the forces of
culture, habits and attitudes that can often snuff out,
smother or mask the urgencies of viewing phenomena as
biological or biomedical. Yet a crucial view prevails: we
seek to fine-tune approaches that could yield analyses of
evidence and ultimately to define mechanisms. Certain
chronic ailments, but perhaps not acute problems, are the
ripest for this modern excursion into integrative medicine.
In my first editorial, I proposed that eCAM, when
rigorous, can be science (1). Happily, this created a stir
and the beginnings of a barrage of invitations to some-
what exotic nations that are the cradles of integrative
approaches: Ayurveda (2–4), Traditional Chinese
Medicine (TCM) (5–7), Kampo (8–10) and Traditional
Arabic and Islamic Medicine (11, 12). These travels were
both inspiring, enlightening and a source for viewing
integrative medicine in the larger human and multi-
cultural context. With a constant vision of eCAM as a
spin-off from biology, I assumed that the publication of
rigorously reviewed papers could be mixed, i.e. those
dealing strictly with animal models (basic science) and
human trials (clinical analyses), both of which often
involve in vitro approaches. I held this view through
volumes 1–3. However, in volume 4, I decided to perhaps
change the focus of reader’s attention and to accomplish
this, I chose to group the basic science papers together
and the clinical analyses together, maintaining the
subjects but as distinct and separate categories—nothing
wrong with that! We classify all the time, art, music,
animals, plants, cultures, etc. In addition, I’ve published
our first supplement (13).
However, I did have another vision and that was to
determine if this separation might draw readers’ attention
to the need for and the active recruiting of clinical
papers. After all eCAM’s title says it all: ‘evidence based’
complementary and alternative medicine. So the instruc-
tions to authors were rewritten to include quite detailed
ways to present clinical data (brief case reports; to
develop case reports with detailed, illustrative documen-
tation; case reports expanded into hypotheses; clinical
studies with as strong an evidence base as possible, etc.)
(14). Moreover, there were other efforts. I was invited to
present Writer’s Workshops at several national meet-
ings of the American College for Advancement in
Medicine (15–18), opening the doors for the works of
clinicians. Instructions in eCAM and Writers’ Workshops
were international, national and local. Moreover, there
were policy-structured international efforts in conjunction
with the World Health Organization (19). These were
meetings designed exclusively for veterinarians recogniz-
ing the utility of animal models in the quest to under-
stand human disease (20–22).
Now, here are the results of this five-year strategy,
mixing and separating basic science and clinical analyses
in volumes 1–5. From a cursory examination, there
seemed to be no significant differences in the numbers of
basic science papers vis-a´-vis the clinical analyses in
volumes 1–3. In volume 4 however, there was twice-
higher the number of basic science papers compared with
clinical analyses. It was with volume 4 that the first
separation began and that situation has prevailed in
volume 5. Thus, despite efforts to raise the number and
quality of clinical submissions, it seems that basic science
papers outnumber the clinical papers in the two most
recent volumes 4 and 5 of eCAM, where there was the
separation and, presumably, greater visibility. This raises
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properly cited.the question—do authors view eCAM as devoted more to
basic science and to do credible work is easier in that
sphere to accomplish than clinical approaches?
Now with volume 6, I question whether this seeming
trend (i.e. toward more basic science papers) in eCAM is
a reflection of a national and international trend. Was
eCAM’s vision to recognize itself as a scientific journal
that lays a foundation for clinical analyses the appro-
priate and meaningful way to visualize itself? Despite this
covert attempt in comparison with the more direct ones,
do the rigors and flavors of science dominate and
embellish eCAM’s strength and existence (23)?
Fortunately, the magazine Science may have a partial
answer and present clues to questions surrounding
clinical papers (Science 322: #5899: 149–328; October
10, 2008). Biomedical funding is in trouble and that is
a cause for alarm in preparing our world’s scientists.
However, I have been struck by a strong publication
devoted to the subject of clinical applications in a special
issue: ‘Clinical Trials and Tribulations’. This opens with
an introduction by Eliot Marshall entitled ‘Lemons,
Oranges and Complexity’. A provocative cover shows
a white-coated investigator pushing a gargantuan white
pill up a mountain. Upon first seeing it, one is not clear if
the mountain is made of blue rocks or piles of blue
paper—in either case, in my opinion, piles of papers (qua
bureaucracy) are as difficult to surmount or conquer as
piles of rocks! According to the description of the cover:
‘Steep terrain’: to move a therapy from the research lab
to the doctor’s office requires a huge investment in
clinical trials, which are growing more costly and more
complex every year. Five pertinent topics are treated and
online material can be viewed at: www.sciencemag.org/
clinicaltrials. So for eCAM, it seems that a clear message
may be emerging. There is a continuing place for basic
science and for clinical analyses. Basic science under girds
the successful attempt at translation from the bench to
the clinic. We need it all: animal models, in vitro assays
and carefully monitored clinical applications. At the same
time, there should be an ever reminder of the paper of
Goldrosen and Strauss (24) that presented the pyramid:
the base or foundation, case reports and the pinnacle:
randomized, controlled, double-blinded trials. This is an
essential hierarchy in approaching biomedical research.
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